Journal Mobile Options
Table of Contents
Vol. 22, No. 3, 2006
Issue release date: August 2006

Rethinking the Dementia Diagnoses in a Population-Based Study: What Is Alzheimer’s Disease and What Is Vascular Dementia?

A Study from the Kungsholmen Project

Agüero-Torres H. · Kivipelto M. · von Strauss E.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Objective: To explore the hypothesis that older adults often are affected by more than one disease, making the differential diagnosis between Alzheimer’s disease (AD) and vascular dementia (VaD) difficult. Methods: Incident dementia cases (n = 308) from a population-based longitudinal study of people 75+ years were investigated. The DSM-III-R criteria were used for the clinical diagnosis of dementia. Data on vascular disorders (hypertension, cerebrovascular and ischemic heart diseases, heart failure, atrial fibrillation, diabetes) as well as type of onset/course of dementia were used retrospectively to reclassify dementias. Results: Only 47% of the AD cases were reclassified as pure AD without any vascular disorder. Among subjects with AD and with a vascular component, cerebrovascular disease was the most common (41%). Only 25% of VaD were reclassified as pure VaD. Further, 26% of the pure AD subjects developed a vascular disorder in the following 3 years. Conclusions: Both vascular and degenerative mechanisms may often contribute to the expression of dementia among the elderly. Most of the AD cases have vascular involvements, and pure dementia types in very old subjects constitute only a minority of dementia cases.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. von Strauss E, Viitanen M, De Ronchi D, Winblad B, Fratiglioni L: Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol 1999;56:587–592.
  2. Agüero-Torres H, Fratiglioni L, Guo Z, Viitanen M, von Strauss E, Winblad B: Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study. Am J Public Health 1998;88:1452–1456.
  3. Agüero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B: Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. J Clin Epidemiol 1999;58:737–743.

    External Resources

  4. Desmond DW: The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit? J Neurol Sci 2004;226:3–7.
  5. Graham NL, Emery T, Hodges JR: Distinctive cognitive profiles in Alzheimer’s disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry 2004:75:61–71.
  6. Agüero-Torres H, Winblad B: Alzheimer’s disease and vascular dementia: some points of confluence. Ann NY Acad Sci 2000;309:547–552.

    External Resources

  7. Groves WC, Brandt J, Steinberg M, Warren A, Rosenblatt A, Baker A, Lyketsos CG: Vascular dementia and Alzheimer’s disease: is there a difference? A comparison of symptoms by disease duration. J Neuropsychiatry Clin Neurosci 2000;3:305–315.
  8. Kalaria R: Similarities between Alzheimer’s disease and vascular dementia. J Neurol Sci 2002;203–204:29–34.
  9. Erkinjuntti T: Diagnosis and management of vascular cognitive impairment and dementia. J Neural Transm Suppl 2002;(63):91–109.

    External Resources

  10. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A: 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141–1145.
  11. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Havlik RJ: Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 2000;21:49–55.
  12. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A: Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study. BMJ 2001;322:1447–1451.
  13. Launer LJ: Demonstrating the case that AD is a vascular disease: epidemiological evidence. Ageing Res Rev 2002;1:61–77.
  14. de la Torre JC: Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002;33:1152–1162.
  15. Chui HC, Mack W, Jackson JE, Mungas D, Reed BR, Tinklenberg J, Chang FL, Skinner K, Tasaki C, Jagust WJ: Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and internal reliability. Arch Neurol 2000;57:191–196.
  16. Stewart R: Vascular dementia: a diagnosis running out of time. Br J Psychiatry 2002;180:152–156.
  17. Roman GC, Sachdev P, Royall DR, Bullock RA, Orgogozo JM, Lopez-Pousa S, Arizaga R, Wallin A: Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 2004;226:81–87.
  18. Roman GC, Royall DR: A diagnostic dilemma: is ‘Alzheimer’s dementia’ Alzheimer’s disease, vascular dementia, or both? Lancet Neurol 2004;3:141.
  19. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafstrom M, Holmen K, Ericsson K, Backman L, Ahlbom A, Winblad B: Prevalence of Alzheimer’s disease and other dementias in an elderly urban population: relationship with age, sex and education. Neurology 1991;41:1886–1892.
  20. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B: Very old women at highest risk of dementia and Alzheimer’s disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 1997;48:132–138.
  21. Folstein MF, Folstein SE, McHugh PR: ‘Mini-Mental State’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  22. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised (DSM-III-R). Washington, American Psychiatric Association, 1987, pp 97–163.
  23. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Winblad B: Clinical diagnosis of Alzheimer’s disease and other dementias in a population survey: agreement and causes of disagreement in applying DSM III-R criteria. Arch Neurol 1992;49:927–932.
  24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task force on Alzheimer’s disease. Neurology 1984;34:939–944.
  25. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:243–245.
  26. Hachinski VC, Illif LD, Zhilka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L: Cerebral blood flow in dementia. Arch Neurol 1975;32:632–637.
  27. Moroney JT, Bagiella E, Desmond DW, Hachinski VC, Molsa PK, Gustafson L, Brun A, Fischer P, Erkinjuntti T, Rosen W, Paik MC, Tatemichi TK: Meta-analysis of the Hachinski Ischemic score in pathologically verified dementias. Neurology 1997;49:1096–1105.
  28. Health Care Financing Administration: The International Classification of Diseases, ed 9. Clinical modifications. DHHS Publ No (PHS) 80-1260. Washington, Government Printing Office, 1980.
  29. Neuropathology Group: Medical Research Council Cognitive Function and Aging Study: pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001;357:169–175.
  30. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, Masaki K, Launer L, Markesbery WR: Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann NY Acad Sci 2002;977:9–23.
  31. Fernando MS, Ince PG, MRC Cognitive Function and Ageing Neuropathology Study Group: Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci 2004;226:13–17.
  32. Joseph J, Shukitt-Hale B, Denisova NA, Martin A, Perry G, Smith MA: Copernicus revisited: amyloid beta in Alzheimer’s disease. Neurobiol Aging 2001;22:131–146.
  33. Kalaria RN, Ballard C: Overlap between pathology of Alzheimer’s disease and vascular dementia. Alzheimer Dis Assoc Disord 1999;13(suppl 3):115–123.

    External Resources

  34. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H: Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 2002;137:149–155.
  35. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR: Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277:813–817.
  36. Sparks DL, Scheff SW, Liu H, Landers TM, Coyne CM, Hunsaker JC 3rd: Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 1995;131:162–169.
  37. Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, Nelson J, Davis DG, Hardman J, Foley DJ, Launer LJ: Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia Aging Study. Neurobiol Aging 2000;21:57–62.
  38. Farkas E, Luiten PG: Cerebral microvascular pathology in aging and Alzheimer’s disease. Prog Neurobiol 2001;64:575–611.
  39. Pasquier F, Leys D, Scheltens P: The influence of coincidental vascular pathology on symptomatology and course of Alzheimer’s disease. J Neural Transm Suppl 1998;54:117–127.
  40. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215–1222.
  41. Ballard CG, Burton EJ, Barber R, Stephens S, Kenny RA, Kalaria RN, O’Brien JT: NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia. Neurology 2004;63:983–988.
  42. Rockwood K, Bowler J, Erkinjuntti T, Hachinski V, Wallin A: Subtypes of vascular dementia. Alzheimer Dis Assoc Disord 1999;13(suppl 3):59–65.

    External Resources

  43. Cosentino SA, Jefferson AL, Carey M, Price CC, Davis-Garrett K, Swenson R, Libon DJ: The clinical diagnosis of vascular dementia: a comparison among four classification systems and a proposal for a new paradigm. Clin Neuropsychol 2004;18:6–21.
  44. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC: Subcortical ischaemic vascular dementia. Lancet Neurol 2002;1:426–436.
  45. Langa KM, Foster NL, Larson EB: Mixed dementia: emerging concepts and therapeutic implications. JAMA 2004;292:2901–2908.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50